Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma

Matthew S. Lara, Alaa M Afify, Michael P. Ellis, Chinh Phan, David P Richman, Jonathan Riess

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
JournalClinical lung cancer
DOIs
StatePublished - Jan 1 2019

Keywords

  • Immune-related adverse events
  • Immunotherapy
  • Myasthenia gravis
  • NSCLC
  • Thymoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this